METTL3-Mediated N6-Methyladenosine Ferroptosis in Sepsis-Associated Acute Lung Injury — A Narrative Review
Frontiers in Bioscience-Landmark · 2025
DOI: 10.31083/fbl31279 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Bioscience-Landmark, 2025. Verfasst von Rinki Kumari und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division. V. Ramalingaswami Bhawan, Indian Council of Medical Research, Epidemiology and Communicable Diseases (ECD), 110029 New Delhi, India. Hauptthemen laut MEDLINE: Adenosine, Methyltransferases, Acute Lung Injury, Ferroptosis. Die Arbeit nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Children's Hospital of Eastern Ontario, Stollery Children's Hospital Foundation and supporters of the Lois Hole Hospital for Women, Canadian Foundation for Women's Health.
Themen: Sepsis
Abstract (Originalsprache)
Sepsis-induced acute lung injury (ALI) represents a complex and life-threatening condition with limited therapeutic options. Recent research has unveiled the role of methyltransferase-like 3 (METTL3)-mediated N6-methyladenosine (m6A) modifications in exacerbating ferroptosis via m6A-insulin-like growth factor 2 mRNA binding protein 2 (IGF2BP2)-dependent mitochondrial metabolic reprogramming, shedding light on potential therapeutic targets. This study delves into the implications, challenges, and prospects of this intricate molecular pathway in sepsis-associated ALI. METTL3-mediated M6A modifications assume a pivotal role in the pathogenesis of sepsis-induced ALI. These modifications exacerbate ferroptosis, a regulated cell death process characterized by iron-dependent oxidative damage to lipids. The involvement of m6A-IGF2BP2-dependent mitochondrial metabolic reprogramming adds another layer of complexity to this mechanism, offering potential therapeutic avenues. Understanding the intricate network of METTL3-mediated m6A modifications, IGF2BP2, and mitochondrial metabolic reprogramming poses a formidable challenge. Developing interventions that modulate this pathway while minimizing off-target effects remains a significant hurdle. Patient-specific responses and identifying reliable biomarkers further complicate the clinical translation of these findings. The unraveling of this molecular pathway holds promise for personalized medicine approaches in ALI management. Early diagnosis and tailored interventions based on individual patient profiles may significantly enhance clinical outcomes. Collaboration among multidisciplinary teams, including researchers, clinicians, and drug developers, is essential to bridge the gap between laboratory discoveries and clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division. V. Ramalingaswami Bhawan, Indian Council of Medical Research, Epidemiology and Communicable Diseases (ECD), 110029 New Delhi, India.
- Department of Advanced Centre for Traditional and Genomic Medicine, Institute of Medical Sciences, Banaras Hindu University, 221005 Varanasi, India.
- Department of Laboratory Medicine and Pathology, University of Alberta Hospital, Edmonton, AB T6G 2B7, Canada.
- Anatomic Pathology, Children's Hospital of Eastern Ontario, University of Ottawa, Ottawa, ON K1H 8L1, Canada.
Förderung
- Children's Hospital of Eastern Ontario
- Stollery Children's Hospital Foundation and supporters of the Lois Hole Hospital for Women
- Canadian Foundation for Women's Health
- Cancer Research Society (von Willebrand factor gene expression in cancer cells)
- Children’s Hospital of Eastern Ontario
- Stollery Children’s Hospital Foundation and supporters of the Lois Hole Hospital for Women
- Canadian Foundation for Women’s Health
Zitieren
APA
Kumari, R., Leng, R., Chiu, B., & Sergi, C. M. (2025). METTL3-Mediated N6-Methyladenosine Ferroptosis in Sepsis-Associated Acute Lung Injury — A Narrative Review. Frontiers in Bioscience-Landmark. https://doi.org/10.31083/fbl31279
Vancouver
Kumari R, Leng R, Chiu B, Sergi CM. METTL3-Mediated N6-Methyladenosine Ferroptosis in Sepsis-Associated Acute Lung Injury — A Narrative Review. Frontiers in Bioscience-Landmark. 2025. doi:10.31083/fbl31279
BibTeX
@article{Kumari2025,
author = {Kumari, Rinki and Leng, Roger and Chiu, Brian and Sergi, Consolato M},
title = {METTL3-Mediated N6-Methyladenosine Ferroptosis in Sepsis-Associated Acute Lung Injury — A Narrative Review},
journal = {Frontiers in Bioscience-Landmark},
year = {2025},
doi = {10.31083/fbl31279}
}
EUVIMED